Pharmacists Advocating for COVID-19 Vaccine Provider Status
Congress is in the middle of discussing this issue, Hogue said, meaning pharmacists need to advocate for provider status immediately.
Pharmacy Times spoke with Michael Hogue, PharmD, president of the American Pharmacists Association (APhA), about the current push in Congress for pharmacists to gain provider status in the push for the coronavirus disease 2019 (COVID-19) vaccine.
Hogue said this status is vital for pharmacists to effectively provide access to the vaccine once it becomes available, particularly because pharmacists are the most accessible health care providers and are able to administer the vaccine to many people very quickly. In addition, Hogue emphasized that pharmacists should get paid for this service similar to other health care professionals.
“There’s been a lot in the media about pharmacists doing [COVID-19] testing,” Hogue said. “However, what’s missing is that we’re asking pharmacists to do it for free. That doesn’t make sense, that’s inequitable.”
Congress is in the middle of discussing this issue, Hogue said, meaning pharmacists need to advocate for provider status immediately. Pharmacists should contact their representatives and encourage other health care professionals to do so as well, Hogue said. The APhA website
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- IMS 2025: Improving Outcomes with Bispecifics in Multiple Myeloma
September 19th 2025
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
September 18th 2025